Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases

Explore clinical trials studying Female Urogenital Diseases. Study availability and eligibility vary by location and protocol.

21,988 public trials 3,764 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases trial results

Recruiting

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

NCT06330064

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +55 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Los Angeles Cancer Network Los Angeles, California, United States
  • Pih Health Hematology Medical Oncology Whittier, California, United States
  • Orchard Healthcare Research Inc Skokie, Illinois, United States
View all 120 locations
View Trial Details
Recruiting

Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery

NCT06476184

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • ICO Paul Papin Angers, France
  • CH d'Avignon Avignon, France
  • Sainte-Catherine Institut du Cancer Avignon-Provence Avignon, France
  • Hôpital de la Côte Basque Bayonne, France
View all 76 locations
View Trial Details
Recruiting

A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer

NCT06245603

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Humanitas Gavezzeni-Bergamo Bergamo, Italy
  • Ospedale Sant'Orsola - Malpighi Bologna, Italy
  • Policlinico Ospedali Riuniti - Foggia Foggia, Italy
  • Istituto Oncologico Veneto IRCCS Padova, Italy
View Trial Details
Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT05579366

Conditions
Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
Locations
  • USOR HonorHealth Phoenix, Arizona, United States
  • USOR Arizona Oncology Associates Tucson, Arizona, United States
  • University of California Los Angeles Medical Center Los Angeles, California, United States
  • University of California, San Diego; Moores Cancer Center San Diego, California, United States
View all 66 locations
View Trial Details
Recruiting

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

NCT06960577

Conditions
Cisplatin, Doxorubicin, Female Urogenital Diseases, +14 more
Locations
  • Research Site Chermside, Australia
  • Research Site Elizabeth Vale, Australia
  • Research Site Heidelberg, Australia
  • Research Site Hong Kong, Australia
View all 59 locations
View Trial Details

Related conditions